Thermo Fisher Scientific Inc (TMO)

555.15 +4.41 (+0.80%)
Closed USD Disclaimer
551.29 -3.86 (-0.70%)

TMO Financial Summary

For the three months ended 02 April 2022, Thermo Fisher Scientific Inc. revenues increased 19% to $11.82B. Net income decreased 5% to $2.22B. Revenues reflect Laboratory products and services segment increase of 51% to $5.44B, Analytical Technologies segment increase of 9% to $1.52B, Life Sciences Solutions segment increase of 1% to $4.23B, North America segment increase of 24% to $6.32B, Asia Pacific segment increase of 21% to $2.06B.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
TMO
Gross margin TTM 48.37%
Operating margin TTM 21.97%
Net Profit margin TTM 18.56%
Return on Investment TTM 10.95%
Total Revenue
Net Income
Title
Apr 02, 2022
Dec 31, 2021
Oct 02, 2021
Jul 03, 2021
Total Revenue 11,818 10,702 9,330 9,273
Gross Profit 5,464 5,254 4,651 4,524
Operating Income 2,821 1,771 2,278 2,163
Net Income 2,215 1,658 1,902 1,828
Clear All
0Selected
Please try another search
TMO
Quick Ratio MRQ 1.1
Current Ratio MRQ 1.56
LT Debt to Equity MRQ 76.64%
Total Debt to Equity MRQ 81.2%
Total Assets
Total Liabilities
Title
Apr 02, 2022
Dec 31, 2021
Oct 02, 2021
Jul 03, 2021
Total Assets 92,747 95,123 73,600 67,698
Total Liabilities 51,791 54,330 34,890 30,844
Total Equity 40,956 40,793 38,710 36,854
Clear All
0Selected
Please try another search
TMO
Cash Flow/Share TTM 26.41
Revenue/Share TTM 103.78
Operating Cash Flow 18.24%
Cash
Net Change in Cash
Title
Apr 02, 2022
Dec 31, 2021
Oct 02, 2021
Jul 03, 2021
Cash From Operating Activities 2,202 9,312 6,855 4,205
Cash From Investing Activities -670 -21,932 -3,240 -2,624
Cash From Financing Activities -3,145 6,581 -1,886 -4,926
Net Change in Cash -1,712 -5,845 1,712 -3,301
Clear All
0Selected
Please try another search

* In Millions of USD (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.